KLF4 functions as an oncogene in promoting cancer stem cell-like characteristics in osteosarcoma cells

[1]  Qiaojun He,et al.  Inhibition of KLF4 by Statins Reverses Adriamycin-Induced Metastasis and Cancer Stemness in Osteosarcoma Cells , 2017, Stem cell reports.

[2]  V. Yang,et al.  Krüppel-like factor 4 (KLF4): What we currently know. , 2017, Gene.

[3]  Suyun Huang,et al.  KLF4-Mediated Suppression of CD44 Signaling Negatively Impacts Pancreatic Cancer Stemness and Metastasis. , 2016, Cancer research.

[4]  Guang-ning Yan,et al.  Advances in osteosarcoma stem cell research and opportunities for novel therapeutic targets. , 2016, Cancer letters.

[5]  A. Cleton-Jansen,et al.  Chemotherapy induces stemness in osteosarcoma cells through activation of Wnt/β-catenin signaling. , 2016, Cancer letters.

[6]  Ning Zhang,et al.  Hypoxia-Induced WSB1 Promotes the Metastatic Potential of Osteosarcoma Cells. , 2015, Cancer research.

[7]  Z. Ji,et al.  MicroRNA-7 inhibits the stemness of prostate cancer stem-like cells and tumorigenesis by repressing KLF4/PI3K/Akt/p21 pathway , 2015, Oncotarget.

[8]  Ning Zhang,et al.  E2F1 impairs all-trans retinoic acid-induced osteogenic differentiation of osteosarcoma via promoting ubiquitination-mediated degradation of RARα , 2014, Cell cycle.

[9]  Z. Liang,et al.  Interleukin-17 produced by tumor microenvironment promotes self-renewal of CD133+ cancer stem-like cells in ovarian cancer , 2013, Oncogene.

[10]  M. Ohira,et al.  Krüppel-like factor 4 (KLF4) suppresses neuroblastoma cell growth and determines non-tumorigenic lineage differentiation , 2013, Oncogene.

[11]  S. Chiou,et al.  Survival of Cancer Stem Cells under Hypoxia and Serum Depletion via Decrease in PP2A Activity and Activation of p38-MAPKAPK2-Hsp27 , 2012, PloS one.

[12]  Qiaojun He,et al.  Human osteosarcoma CD49f−CD133+ cells: impaired in osteogenic fate while gain of tumorigenicity , 2012, Oncogene.

[13]  R. Weinberg,et al.  Cancer stem cells and epithelial-mesenchymal transition: concepts and molecular links. , 2012, Seminars in cancer biology.

[14]  Fang Yu,et al.  Kruppel-like factor 4 (KLF4) is required for maintenance of breast cancer stem cells and for cell migration and invasion , 2010, Oncogene.

[15]  Toshio Mori,et al.  Possible involvement of stem-like populations with elevated ALDH1 in sarcomas for chemotherapeutic drug resistance. , 2010, Oncology reports.

[16]  N. Agarwal,et al.  CD117 and Stro-1 identify osteosarcoma tumor-initiating cells associated with metastasis and drug resistance. , 2010, Cancer research.

[17]  Y. Takakura,et al.  Sphere-forming stem-like cell populations with drug resistance in human sarcoma cell lines. , 2009, International journal of oncology.

[18]  T. Triche,et al.  Intrinsic Retinoic Acid Receptor α‐Cyclin‐Dependent Kinase‐Activating Kinase Signaling Involves Coordination of the Restricted Proliferation and Granulocytic Differentiation of Human Hematopoietic Stem Cells , 2007, Stem cells.

[19]  F. Gouin,et al.  Recent advances in the management of osteosarcoma and forthcoming therapeutic strategies , 2007, Expert review of anticancer therapy.

[20]  Irving L Weissman,et al.  Cancer stem cells--perspectives on current status and future directions: AACR Workshop on cancer stem cells. , 2006, Cancer research.

[21]  Kanyawim Kirtikara,et al.  Sulforhodamine B colorimetric assay for cytotoxicity screening , 2006, Nature Protocols.

[22]  R. Bernards,et al.  The KLF4 tumour suppressor is a transcriptional repressor of p53 that acts as a context-dependent oncogene , 2005, Nature Cell Biology.

[23]  Edward W Scott,et al.  Stem-like cells in bone sarcomas: implications for tumorigenesis. , 2005, Neoplasia.

[24]  Michael Dean,et al.  Tumour stem cells and drug resistance , 2005, Nature Reviews Cancer.

[25]  W. Piacibello,et al.  Involvement of chemokine receptor 4/stromal cell-derived factor 1 system during osteosarcoma tumor progression. , 2005, Clinical cancer research : an official journal of the American Association for Cancer Research.

[26]  N. Wang,et al.  The PGI-KLF4 pathway regulates self-renewal of glioma stem cells residing in the mesenchymal niches in human gliomas. , 2014, Neoplasma.

[27]  K. Xie,et al.  Emerging role of KLF4 in human gastrointestinal cancer. , 2006, Carcinogenesis.